LATEST PSYCHEDELICS STOCKS NEWS

53 views0 min read

Braxia Scientific CEO to Deliver Keynote Address at H.C. Wainwright & Co. 1st Annual Mental Health Conference: Neuropsychiatry, Psychedelics, and Beyond

Braxia Scientific
ReutersCryptoverse: Holding your breath for a bitcoin bounceBitcoin's slide since May, swamped by economic angst, has knocked it below its 200-week moving average, at around $22,600, as well as its 200-day moving average around $35,500. Valkyrie Investments, for one, says its research is pointing to an upside move - but that it isn't clea... Read More...
1135 views0 min read

Red Light Holland and Superstar Wiz Khalifa to Launch Naturally Occurring Psilocybin and Mushrooms Wellness Brand: Mistercap

Red Light Holland
ReutersCryptoverse: Holding your breath for a bitcoin bounceBitcoin's slide since May, swamped by economic angst, has knocked it below its 200-week moving average, at around $22,600, as well as its 200-day moving average around $35,500. Valkyrie Investments, for one, says its research is pointing to an upside move - but that it isn't clea... Read More...
39 views4 min read

Delic Labs President and CSO Dr. Markus Roggen Named to Cannabis Scientist Power List for Third Consecutive Year

Delic Holdings
Under Dr. Roggen's leadership, Delic Labs will transfer their expertise and experience from the cannabis sector to establish itself as the leader in psychedelic research and safety testing. The lab has received Health Canada 56 exemptions for chemistry analytics on psilocybin mushrooms; to perform research and tests on a host of compound... Read More...
231 views8 min read

Allied Corp Successfully Ships Second Commercial Cannabis Flower Export From Colombia to International Market

Allied
KELOWNA, British Columbia, July 14, 2022 -- Allied Corp. ("Allied" or the “Company”) (OTCQB: ALID) is pleased to announce that it has completed its second shipment of commercial dried cannabis from Colombia to an international market. On April 01, 2022 Colombia enacted the new legislation allowing for the legal export of dried cannabis pr... Read More...
876 views4 min read

Optimi Health Finalizes Psilocybin Supply Agreement With Bloom Psychedelic Therapy And Research Centre

Optimi Health
VANCOUVER, British Columbia, July 13, 2022 -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), a homegrown, Canadian company cultivating and synthesizing high quality psychedelics and natural functional and psilocybin mushroom strains for transformational human experiences, is pleased to announce that... Read More...
1043 views2 min read

Silo Pharma Announces Positive Results in Subcutaneous Delivery of its Novel Liposomes to Treat Arthritic Patients

Silo Pharma
ENGLEWOOD CLIFFS, N.J, July 12, 2022 -- Silo Pharma, Inc . (OTCQB: SILO), a development-stage biopharmaceutical company today announces that its novel liposomes reached a positive endpoint in animal studies showing effectiveness and reduced toxicity using a subcutaneous delivery method. Eric Weisblum, CEO of Silo Pharma commented “The suc... Read More...
1006 views4 min read

Lobe Sciences Ltd. Announces Regulatory and Clinical Development Plans For 2022 and Early 2023

Lobe Sciences
Vancouver, British Columbia--(Newsfile Corp. - July 7, 2022) - Lobe Sciences Ltd. (CSE: LOBE) (OTCQB: LOBED) ("Lobe"), a Canadian Biotechnology company committed to discovering and developing psychedelic derived medicines today announced it has developed its initial Phase 1 study plan intended to demonstrate the safety and appropriate dos... Read More...
384 views7 min read

Pure Extracts Provides Q3 Corporate Update

Pure Extracts Technologies
VANCOUVER, British Columbia, July 07, 2022 -- Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) (“Pure Extracts” or the “Company”), a plant-based extraction company focused on cannabis, hemp and the rapidly emerging psychedelic sector, is pleased to provide a brief summary of recent activities. The Summer season has... Read More...
885 views4 min read

Algernon Pharmaceuticals Provides Update on Its Phase 1 DMT Stroke Study

Algernon Pharmaceuticals
VANCOUVER, British Columbia, July 07, 2022 -- Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a clinical stage Canadian pharmaceutical development company, is pleased to provide an update on its planned Phase 1 clinical human study of AP-188 (“N,N-dimethyltryptamine” or “DMT”). DMT ... Read More...
891 views5 min read

Algernon Pharmaceuticals Discloses Novel DMT Salt Patent Strategy Includes Bioactive Nicotinate and Pamoate

Algernon Pharmaceuticals
VANCOUVER, British Columbia, July 05, 2022 -- Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF) a clinical stage pharmaceutical development company is pleased to disclose that as part of its intellectual property patent applications filed in early 2021 for AP-188 (“N,N-dimethyltryptami... Read More...
1064 views3 min read

Pure Extracts Signs Listing Agreement with Shoppers Drug Mart and Receives Initial Purchase Order

Pure Extracts Technologies
VANCOUVER, British Columbia, June 30, 2022 -- Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) (“Pure Extracts” or the “Company”), a plant-based extraction company focused on cannabis, hemp and the rapidly emerging psychedelic sector, is pleased to announce that its wholly-owned subsidiary, Pure Extracts Manufactur... Read More...
Financials370 views27 min read

Field Trip Health Ltd. Reports Fiscal Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update Including Corporate Reorganization

Field Trip Health
Completed strategic review and announced intention to separate the Field Trip Discovery and Field Trip Health divisions into two independent public companies.Earned patient services revenues of $1.7 million in fiscal fourth quarter, an increase of 26.7% over the prior quarter and 228% year over year. Full year patient services revenue was... Read More...
441 views6 min read

Field Trip Health Ltd. Receives Final Court Approval for Reorganization of the Discovery and Wellness Businesses Into Two Publicly Traded Companies

Field Trip Health
- Closing of arrangement subject to regulatory approvals, including conditional listing approval by the TSX Venture Exchange.- Closing of the arrangement expected to occur in August.- Also announces closing of subscription receipt offering. TORONTO, June 29, 2022 -- Field Trip Health Ltd. (TSX: FTRP, FTRP.WT, Nasdaq: FTRP) ("Field Trip" ... Read More...
1230 views8 min read

Allied Corp Successfully Ships First Commercial Cannabis Flower Export From Colombia to International Market

Allied
KELOWNA, British Columbia, June 29, 2022 -- Allied Corp. ("Allied" or the “Company”) (OTCQB: ALID) is pleased to announce that it has completed the first shipment of commercial dried cannabis from Colombia to an international market. On April 01, 2022 Colombia enacted the new legislation allowing for the legal export of dried cannabis pro... Read More...
386 views7 min read

Red Light Holland Update Plans to Enter Oregon Legal Psilocybin Service Market to Promote Diversity and Equity in Alignment with Measure 109 Regulations

Red Light Holland
● Red Light Holland launches: 'Red Light. Set. Go!' program to work with exceptional local Oregonians from diverse backgrounds who wish to enter the legal psilocybin service market.● Shunji Smith, Japanese American avid mushroom grower, teacher, and small business owner from Eugene, Oregon joins the program.● Red Light Holland and Halo Co... Read More...
1399 views8 min read

Optimi Health Initiates Agreement With SABI Mind For Therapeutic Supplies Of Psilocybin, MDMA

Optimi Health
Optimi Health Corp.Optimi Health Cultivation and Analytical FacilitiesOptimi Health Cultivation and Analytical FacilitiesOptimi Health Fruiting RoomOptimi Health fruiting room being prepared for second grow.VANCOUVER, British Columbia, June 28, 2022 -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), ... Read More...
905 views3 min read

Pure Extracts Receives Purchase Order for a New Listing of High-Potency Vape Carts from the Ontario Cannabis Store

Pure Extracts Technologies
VANCOUVER, British Columbia, June 28, 2022 -- Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) (“Pure Extracts” or the “Company”), a plant-based extraction company focused on cannabis, hemp, functional mushrooms and the rapidly emerging psychedelic sector, is pleased to announce that its wholly-owned subsidiary, Pu... Read More...
1279 views5 min read

Numinus Unveils New Logo and Brand Identity

Numinus Wellness
New branding unifies Numinus' presence across North America Rebranding will be accomplished in phases and completed by end of 2022 VANCOUVER, BC, June 27, 2022 - Numinus Wellness Inc. ("Numinus", the "Company") (TSX: NUMI) (OTCQX: NUMIF) is pleased to announce the launch of a new visual brand identity that will be applied to all Company ... Read More...
107 views4 min read

Bright Minds Biosciences Announces Changes to its Executive Leadership Team, Marking the Transition to a Development Organization

Bright Minds Biosciences
VANCOUVER, British Columbia, June 27, 2022 -- Bright Minds Biosciences (“Bright Minds,” “BMB” or the “Company”) (Nasdaq: DRUG) (CSE: DRUG), a biotechnology company focused on developing novel drugs for the targeted treatment of neuropsychiatric disorders, epilepsy, and pain, today announced that Dr. Alan Kozikowski will no longer serve in... Read More...
866 views2 min read

Silo Pharma Expands License Agreement and Patent Portfolio

Silo Pharma
Silo Enters into Commercial Evaluation License Agreement for Next Generation Liposomes Therapeutics Would Target Multiple Diseases Including Auto Immune Disorders ENGLEWOOD CLIFFS, N.J., June 23, 2022 -- Silo Pharma, Inc. (OTCQB: SILO), a development-stage biopharmaceutical company focused on the use of traditional and psychedelics as a t... Read More...
Calendar65 views4 min read

Delic Corp to Present Vision for Long-Term Growth and Industry-Leading Clinic Developments at First Annual H.C. Wainwright Mental Health Conference

Delic Holdings
June 27, 2022Held at the Lotte New York Palace Hotel, the inaugural event will feature a full day of company presentations, networking opportunities and one-on-one investor meetings with a focus on neuropsychiatry, psychedelics and more. During this year's conference, Stang will deliver a presentation that highlights the company's strateg... Read More...
73 views3 min read

BetterLife To Participate at the H.C. Wainwright 1st Annual Mental Health Conference

BetterLife Pharma
VANCOUVER, British Columbia, June 23, 2022 -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on the development and commercialization of cutting-edge treatments for mental disorders, today announced that Dr. Ahmad Doroudian, Chief Executive Officer, will p... Read More...
Calendar442 views4 min read

Field Trip Health Ltd. to Present at the H.C. Wainwright 1st Annual Mental Healthcare Conference on June 27, 2022

Field Trip Health
TORONTO, June 23, 2022 -- Field Trip Health Ltd. (TSX: FTRP, FTRP.WT, Nasdaq: FTRP) ("Field Trip"), a global leader in the development and delivery of psychedelic therapies, announced today that Field Trip’s Co-founder and Executive Chairman, Ronan Levy, and Chief Scientific Officer, Dr. Nathan Bryson, will participate in a live fireside ... Read More...
CalendarFinancials1131 views5 min read

Field Trip Health Ltd. Schedules Fiscal Fourth Quarter and Full Year 2022 Results Conference Call for Thursday, June 30, 2022 at 8:30 AM ET

Field Trip Health
TORONTO, June 22, 2022 -- Field Trip Health Ltd. (TSX: FTRP, FTRP.WT, Nasdaq: FTRP) ("Field Trip"), a global leader in the development and delivery of psychedelic therapies, announced today that it plans to release financial results for its fiscal fourth quarter and full year ended March 31, 2022, after market close on Wednesday, June 29,... Read More...
Calendar930 views3 min read

Numinus to Participate in the H.C. Wainwright 1st Annual Mental Health Conference on June 27, 2022

Numinus Wellness
VANCOUVER, BC, June 21, 2022 - Numinus Wellness Inc. ("Numinus") (TSX: NUMI) (OTC: NUMIF), a mental health care company advancing innovative treatments and safe, evidence-based psychedelic-assisted therapies, today announced that it will participate in the H.C. Wainwright 1st Annual Mental Health Conference to be held at the Lotte New Yor... Read More...
70 views4 min read

Lobe Sciences Ltd. and Clearway Global LLC Enter into a Development Agreement to Manage Lobe Sciences Ltd.’s Global Regulatory and Development Strategy and its Implementation

Lobe Sciences
Vancouver, British Columbia--(Newsfile Corp. - June 21, 2022) - Lobe Sciences Ltd. (CSE: LOBE) (OTCQB: LOBED) ("Lobe"), a Canadian Biopsychedelics company committed to discovering and developing psychedelic inspired medicines for the improvement of neurologic, brain and mental health disorders, today announced an exclusive agreement with ... Read More...
M & A1187 views7 min read

Red Light Holland Closes Acquisition of 100 Acres of Farmland in Ontario, Canada Expanding its Mushroom Farms Division in North America

Red Light Holland
Purchase of 100 acres farmland for $1.85 MillionThrough experienced partners, Red Light's Farm Division plan on growing mushroom production with projected additional 65,000 sq. feet of "Innovative and Unique" Mushroom production facilities Mike Medeiros (AEM Partner, Carleton Mushroom Farm co-owner and President of Mushrooms Canada) excit... Read More...
1094 views6 min read

Field Trip Health Ltd. Announces Increased Participation in Arrangement Financing and Postponement of Shareholder Meeting Date

Field Trip Health
TORONTO, June 14, 2022 -- Field Trip Health Ltd. (TSX: FTRP, FTRP.WT, Nasdaq: FTRP) (the "Company" or "Field Trip"), a global leader in the development and delivery of psychedelic therapies, announced today that it has agreed to increase its participation in the concurrent financing, in support of, and in connection with, the spin-out of ... Read More...
M & A560 views3 min read

Novamind Obtains Final Order for Plan of Arrangement from the Supreme Court of British Columbia and Completes Acquisition by Numinus Wellness Inc.

Novamind
TORONTO, ON / ACCESSWIRE / June 10, 2022 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind"), a leading mental health company specialized in psychedelic medicine, announced today that the Company has completed its previously announced acquisition by Numinus Wellness Inc. (TSX:NUMI)(OTCQX:NUMIF) ("Numinus") by way of a plan of arra... Read More...





Make smarter investment strategies
with in-depth news reports

Join our subscribers!